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HemodialysisAbstract Background: Electrical Cardiometry allows measurement of ﬂuid status using thoracic
ﬂuid content (TFC), cardiac output, cardiac index, systemic vascular resistance index which could
be ideal noninvasive hemodynamic monitoring for patients undergoing hemodialysis (HD). Objec-
tives: Investigating the relation between changes in TFC and amount of ﬂuid removal during HD
session and to monitor hemodynamic parameters to avoid episodes of hemodynamic compromise
during HD session. Methods: Thirty critically ill patients on HD were enrolled. Clinical assessment
of volume overload and hemodynamics (BP, MAP, CVP), monitored by Electrical Cardiometry
ICON before HD and all through sessions. Results: Out of studied patients males represented
46.7% (n= 14) with mean age 48 ± 16 years. There was positive correlation between UF volume
and TFC (r= 0.410, P= 0.025). Out of the 30 pts studied 18 pts (60%) were hemodynamically
stable vs 12 pts (40%) that had hypotension represented by non responders group and had lower
TFC compared to the hemodynamically stable group (26.45 kohm1 vs 37.8 kohm1) with P value
of 0.004 indicating that they were hypovolemic. Out of the 30 pts studied 18 pts (60%) weren’t con-
gested vs 12 pts (40%) remained persistently congested after accomplishing HD session with signif-
icantly higher TFC when compared to those who got rid of congestion (43.14 ± 9.9 kohm1 vs
25.44 ± 5.5 kohm1) with P value of 0.0001 indicating that they were still hypervolemic. Using
analysis of ROC curve TFC at 25.34 kohm1 was a signiﬁcant predictor of hypotension with P
value of 0.002, AUC 83.4%, sensitivity 67% and speciﬁcity 100%. Also TFC cutoff value predicting
persistent congestion was 37.02 kohm1 with P value of 0.0001, AUC 95.8%, sensitivity 83% and
58 K.H. Mahmoud et al.speciﬁcity 100%. Conclusion: Electrical Cardiometry is an evolving noninvasive tool for adjusting
ﬂuid status of critically ill patient on RRT using thoracic ﬂuid content as an indicator of ﬂuid status
that could be used to avoid hemodynamic instability and persistent volume overload and congestion
during and after HD session.
 2016 The Egyptian College of Critical Care Physicians. Production and hosting by Elsevier B.V. This is
an open access article under theCCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Table 1 Chest radiography grading deﬁnitions [7].
Garde Chest X-ray grading1. Introduction
Intradialytic hypotension and orthostatic hypotension after
the procedure are signiﬁcant and independent risk factors
affecting mortality in dialysis patients [1].
Several noninvasive methods for hemodynamic monitoring
and determination of ﬂuid status of critically ill patients have
been developed. That can aid the intradialytic assessment of
ﬂuid removal objectively and avoid hemodynamic instability
[2].
Impedance cardiography (ICG) and Electrical Cardiometry
(EC) are recently developed technologies to measure thoracic
ﬂuid content (TFC), cardiac output (CO) and other hemody-
namic parameters. Both ICG and EC derive CO from mea-
surements of Thoracic Electrical Bioimpedance (TEB) [3].
TEB is the electrical resistance to high frequency low ampli-
tude current that is transmitted from electrodes placed on the
upper and lower thorax. The resultant value is indirectly pro-
portional to the volume of thoracic ﬂuids such that increasing
ﬂuid in the thorax results in less TEB. Therefore, the inverse of
TEB, and thus changes in CO, are reﬂected as a change in total
bioimpedance or ﬂuid conductivity [3].
One of the parameters examined is thoracic ﬂuid content
(TFC), which is inversely associated with the patient’s
transthoracic electrical bioimpedance, and reﬂects the total
(intravascular and extravascular) ﬂuid volume contained in
the chest cavity [4].
The ﬂuid content is a pronouncedly variable parameter of a
human’s chest and this is why the dynamic measurements of
chest impedance by means of ICG can reliably and accurately
reﬂect its alterations. Potential changes in thoracic ﬂuid con-
tent are directly proportional to total ﬂuid changes; thus,
ICG and EC parameters can prove to be extremely signiﬁcant
for the monitoring of thoracic blood volume changes during
hemodialysis (HD) session [5].
The aim of our study was to investigate the relation
between changes in the TFC and the amount of ultra ﬁltration
ﬂuid volume and to provide a means of easily tracking ﬂuid
status during hemodialysis, to help in adjusting ﬂuid removal
(rate and amount). Secondly to continuously monitor hemody-
namic parameters with the ultimate goal of understanding how
monitoring patients with this system can help to avoid epi-
sodes of clinically signiﬁcant hemodynamic compromise.
Grade 0 Normal pulmonary vascular distribution
Grade 1 Stage 1 pulmonary venous hypertension: vascular
redistribution due to hypoxia induced basilar
vasoconstriction from non visualized early edema
Grade 2 Stage 2 pulmonary venous hypertension: vascular
redistribution due to early ‘‘peribronchial cuﬃng”
or late ‘‘Kerly’s B line” interstitial edema
Grade 3 Stage 3 pulmonary venous hypertension: vascular
redistribution and perihilar pulmonary edema2. Patients and methods
Our study was designed as a cross-sectional study that was
conducted between June 2014 and March 2015 in the critical
care medicine department of Cairo university hospitals.
The study enrolled thirty critically ill patients on renal
replacement therapy admitted because of renal failure (acuteor chronic), AND/OR ﬂuid overload due to cardiac or hepatic
causes. Patients less than 18 years old, with implantable car-
diac pace maker or deﬁbrillator, signiﬁcant valvular lesions
and pleural effusion, pregnant females, end stage hepatic, car-
diac or pulmonary diseases, terminal malignancy and patients
refused to participate in the study were excluded.
The study was approved by our local scientiﬁc and ethics
committee. All enrolled patients had signed an informed con-
sent for participation in the study and subjected to detailed his-
tory taking and thorough clinical examination for clinical signs
of volume overload including congested neck veins, orthopnea,
rales on chest auscultation, and lower limb edema. Weighing
the patient before and after HD session, CVP measurement
before and after HD session and SBP, DBP and MAP mea-
surement every 30 min, full laboratory investigations including
blood gases, electrolytes and renal function, 12 lead ECG
recordings and routine echocardiography examination includ-
ing assessment of systolic function by 2D imaging, Doppler
and M mode function, measurement using ATL machine 33
with 3.5 mHz probe.
Chest X-ray examination for detection of pulmonary con-
gestion, abnormal chest X-ray was deﬁned as having abnormal
ﬂuid (pulmonary congestion) if they were graded 1, 2 or 3
Table 1 [6,7].
All patients were monitored during HD session using new
model ‘‘EC” based device (ICON) starting 15–30 min prior
to HD and every 30 min thereafter, with a 15 to 30 min stabi-
lization period after the termination of HD session.
The Electrical Cardiometry monitor (Electrical Cardiome-
try monitor, ICON Cardiotronics, Inc.) was connected to
the sensor cable and the patient data were fed. The ICON
monitor incorporates an algorithm which transforms the
ohmic equivalent of mean aortic blood ﬂow acceleration into
an equivalent of mean aortic blood ﬂow velocity.
The ICON device emits a high frequency (50 kHz) and
low-amperage (2 mA) alternating electrical current of constant
amplitude via a pair of surface electrodes across the left side of
the thorax. The voltage drop due to the current application is
Table 2 Study population characteristics.
All
(n= 30)
Responders
(n= 18)
Non
responders
(n= 12)
P value
Age (years) 48.5 ± 16.5 47.94 ± 16.53 49.25 ± 17.3 0.837
Gender (M) 14 (46.6%) 8 (26.6%) 6 (20%) 1.0
Smoking 9 (30)% 6 (20%) 3 (10%) .704
DM 14 (46.7%) 8 (26.7%) 6 (20%) 1.000
HTN 19 (63.3%) 13 (43.3%) 6 (20%) .395
ARF 25 (83.3%) 13 (43.3%) 12 (40%) .066
CRF 5 (16.7%) 6 (20%) 0 (0%) .057
CHD 4 (13.3%) 1 (3.3%) 3 (10%) .274
Com CLD 6 (20%) 4 (13.3%) 2 (6.7%) 1.000
Chest inf. 11 (36.7%) 4 (13.3%) 7 (23.3%) .063
DCL 4 (13.3%) 1 (3.3%) 3 (10%) .274
SLE 4 (13.3%) 3 (10%) 1 (3.3) .255
Sepsis 6 (20%) 5 (16.7%) 1 (3.3%) 0.358
M: male, DM: diabetes mellitus, HTN: hypertension, ARF: acute
renal failure, CRF: chronic renal failure, CHD: coronary heart
disease, Com CLD: compensated chronic liver disease, inf.: infec-
tion, DCL: disturbed conscious level, SLE: systemic lupus.
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which were located at the left side of the neck and the left side
of the thorax at the level of the xiphoid process, inside the cur-
rent electrodes. Prior to opening of the aortic valve, the red
blood cells assume a random orientation (there is no blood
ﬂow in the aorta). After aortic valve opening, the pulsatile
blood ﬂow forces the red blood cells to align in parallel with
the blood ﬂow, the change from random orientation to align-
ment of red blood cells upon opening of aortic valve generates
a characteristic steep increase of conductivity or dZ (t) (corre-
sponding to a steep decrease of impedance) beat to beat [8].
The following Hemodynamic Parameters measured by
ICON thoracic ﬂuid content (TFC), cardiac index (CI) by
body surface area CI (BSA) and by weight CI (WT), mean
arterial pressure (MAP), systemic vascular resistance (SVR)
and systemic vascular resistance index (SVRI) by body surface
area SVRI (BSA) and weight SVRI (WT), these parameters
will be measured before starting HD session by 15 min (zero
reading 0) after 30 min (1st reading), after 1 h (2nd reading),
after 2 h (3rd reading), after 3 h (4th reading), after the end
of the session of HD by 15–30 min (5th reading).
The patients were subjected to intermittent HD sessions
using Hemodialysis Machine, FRESENIUS 4008S. Nephrol-
ogy staff according their policy tailored the protocol of HD
session.
Data of HD session were recorded including blood ﬂow
(BF) pump, blood ﬂow (BF) pump change, UF rate, UF vol-
ume, and complications during HD.
 The study population were further subdivided into two
groups, responders and non-responders as guided by
the clinical assessment of volume overload or Hemody-
namic stability:
o Responders were deﬁned as those who were not con-
gested at the end of HD session as guided by clinical
assessment of signs of congestion mentioned previously
or remained hemodynamically stable.
o Non-responders those who were still congested at the end
of HD session or developed hypotension (a decrease in
SBPP 20 mmHg or MAP> 10 mmHg) and/or associ-
ated with symptoms that were relieved by cessation of
ultra ﬁltration or HD session, decrease blood pump ﬂow
rate and/or improved with administration of bolus
saline.
Statistical analysis was done using Statistical Package for
Social Sciences (SPSS) software, 22 license for WindowsTM
(SPSS Inc., Chicago, Illinois). Quantitative variables were
described using mean ± standard deviation (SD) if they were
normally distributed. Categorical variables were described
using frequencies and percentages. Bivariate analysis of cate-
gorical variables was done using Chi Square test with Yates
Continuity correction for 2  2 tables. Whenever cell fre-
quency was less than ﬁve, Fisher’s Exact test was used. Com-
paring two groups of quantitative variable was done using
Independent-Samples Student t test for parametric data, and
Mann–Whitney test for non-parametric one. The correlation
between two quantitative variables was explored using Pearson
test for parametric data and Spearman’s test for non-
parametric one. In all cases, the 2-sided signiﬁcance was alwaystaken as p value, and a p value less than 0.05 was considered
statistically signiﬁcant.
3. Results
Our study included thirty critically ill pts, who had IHD ses-
sion in the critical care medicine department. The age distribu-
tion of the study population ranged between 21 and 74 years
(mean 48.5 ± 16.5). 53.3% of the study groups were females
while males represented 46.7%. Out of 30 patients, 12 (40%)
pts were still congested at the end of the HD session and 12
(40%) pts experienced hypotension and were deﬁned as non
responders, there was no statistically signiﬁcant difference
regarding demographic and co-morbid conditions in the study
groups with P value > 0.05 Table 2.
In our study, we found that, TFC before HD sessions was
statistically correlated with CI (BSA) 0 before HD session with
r= 0.410 and P= 0.025, as well CVP before HD session with
r= 0.546 and P= 0.003 Fig. 1.
There was a signiﬁcant positive correlation between TFC5
and CI (BSA) 5 after HD session with r= 0.557 and
P= 0.001, CVP after HD session with r= 0.389, P= 0.041
Fig. 2.
There was a signiﬁcant positive correlation between TFC
change (DTFC) with CI (BSA) 5 after HD session with
r= 0.484, P= 0.007, while it was negative correlation with
MAP0 before HD session with r= 0.394, P= 0.031, SVR
5 after HD session with r= 0.434, P= 0.016 and SVRI
(BSA) 5 with r= -0.389, P= 0.05 Fig. 3.
Similarly, % DTFC had nearly same correlation as DTFC.
We found a statistically signiﬁcant positive correlation
between UF volume and TFC (r= 0.40, P= 0.029), DTFC
(r= 0.429, P= 0.018), % DTFC (r= 0.387, P= 0.035),
while there was no statistically signiﬁcant correlation with
CI, SVR, SVRI P> 0.05.
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Figure 1 Correlation between TFC before HD and (A) CI0, (B) CVP before HD.
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Figure 2 Correlation between TFC after HD and (A) CI5, (B) CVP after HD session.
60 K.H. Mahmoud et al.We thoroughly analyzed pts who had persistent congestion,
we found there was a statistically signiﬁcant difference between
responder and nor responders regarding congested NVs and
pulmonary congestion, congestion in CXR and normal CXR
P< 0.05. Mean CVP dropped from mean of 14 ± 5.4 cm
H2O before HD session to mean of 11.14 ± 5 cm H2O after
HD session. Similarly weight dropped from mean of 71.9
± 16.7 kg before HD session to mean of 71.03 ± 16.44 kg
after HD session, with no statistically signiﬁcant difference in
study groups p> 0.05.
There was no statistically signiﬁcant difference between
responders and non responders regarding UF volume and rate,
blood ﬂow (BF) pump rate and change (pP 0.05) as shown in
Table 3.
There was a statistically signiﬁcant difference regarding
TFC 0, 5, average TFC and % DTFC (p< 0.05), while there
was no statistically signiﬁcant difference regarding DTFC
(p> 0.05), as shown in Table 4.
Also, there was a statistically signiﬁcant difference between
responders and non responders regarding CI 0, 5 (BSA) and
average CI (BSA) with p 6 0.05. There was no statistically sig-
niﬁcant difference between responders and non responders
regarding MAP, SVR and SVRI (BSA) with p> 0.05.
ROC curves were plotted to determine the cutoff value of
TFC to predict persistent congestion Fig. 4, which was
35.66 kohm1 at the beginning of HD session with P value
of 0.0001, AUC 91.2%, sensitivity 88.9% and speciﬁcity
83.3%, Also TFC at the end of HD session was 34.38 kohm1
with P value of 0.0001, AUC 98.6%, sensitivity 91% and
speciﬁcity 100%, while average TFC cutoff value was37.02 kohm1 with P value of 0.0001, AUC 95.8%, sensitivity
83% and speciﬁcity 100%.
We thoroughly analyzed pts who had hypotension, we found
that, there was no statistically signiﬁcant difference between
responders and nor responders regarding congested NVs and
pulmonary congestion, LL edema P> 0.05. Mean CVP
dropped from mean of 14 ± 5.4 cm H2O before HD session to
mean of 11.14 ± 5 cm H2O after HD session. Similarly weight
dropped from mean of 71.9 ± 16.7 kg before HD session to
mean of 71.03 ± 16.44 kg afterHD session, with no statistically
signiﬁcant difference in study groups with p> 0.05. There was a
statistically signiﬁcant difference between responders and non
responders regarding blood ﬂow (BF) pump rate and BF pump
change (p= 0.002 and 0.0001) respectively while there was no
signiﬁcant difference between responder and non responders
regarding UF volume and rate (p> 0.05) Table 5.
There was a statistically signiﬁcant difference between
responders and non responders regarding TFC 0, 5 and aver-
age TFC (p< 0.05), while there was no statistically signiﬁcant
difference regarding DTFC and % DTFC (p> 0.05), as shown
in Table 6.
Also there was a statistically signiﬁcant difference between
responders and non responders regarding MAP 5 and average
MAP with p< 0.05, whereby there was a drop of MAP values
in non responders group from 92 ± 16.7 mmHg to 83
± 17.2 mmHg. In contrast MAP in responders group was
changed during HD session then returned to the same value
at beginning of the HD session (97.3 ± 1.31 mmHg, 94.5
± 10.7 then 97.3 ± 11.4 mmHg at the end). There was no
statistically signiﬁcant difference between responders and
Figure 3 +ve correlation between DTFC and CI after HD (A), ve correlation between DTFC before HD, SVR and SVRI after HD (B
and C).
Table 3 Comparison between responders and non responders according to HD parameters.
HD parameters Responders Non responders P value
Mean ± SD Mean ± SD
UF volume ml/session 1500 ± (1237) 1917 ± (1311) 0.329
UF rate ml/h 479 (415) 575 ± (340) .513
BF Pump rate ml/h 248 ± (36) 229 ± (33) .169
No. & % No. & %
BF pump change 5 (17.7%) 2 (6.7%) 0.66
Electrical Cardiometry in non invasive adjustment of ﬂuid status in renal patients 61non responders regarding CI (BSA), SVR and SVRI (BSA)
with p> 0.05.
ROC curves were plotted to determine the cutoff value of
TFC to predict hypotension Fig. 5, which was 26.6 kohm1
at the beginning of HD session with P value of 0.001, AUC85%, sensitivity 94.4% and speciﬁcity 75%. Also TFC at the
end of HD session was 26.2 kohm1 with P= 0.01, AUC
78.2%, sensitivity 88.9% and speciﬁcity 75%, while average
TFC cutoff value was 25.34 kohm1 with P value of 0.002,
AUC 83.4%, sensitivity 67% and speciﬁcity 100%.
Table 4 Comparison between responders and non responders in relation to TFC by ICON.
TFC by ICON Responders Non responders P value
Mean ±SD Mean ±SD
TFC0 27.24 6.46 42.55 10.34 0.0001
TFC5 25.44 5.57 43.90 9.14 0.0001
Average TFC 26.67 6.32 43.14 9.49 0.0001
DTFC 1.805 2.561 1.349 6.043 0.058
% DTFC 5.90 8.23 5.72 21.20 0.044
Figure 4 ROC curve for prediction of persistent congestion.
Table 5 Comparison between responders and non responders according to HD parameters.
HD parameters Responders Non responders P value
Mean ±SD Mean ±SD
UF rate ml/h 605.83 431.43 384.17 260.99 0.12
UF volume ml/session 1972 1334 1208 1033 0.11
BF Pump rate ml/hr 225 25.72 263.25 37.51 0.002
No. % No. %
BF Pump change 0 0 7 23.3 0.0001
Table 6 Comparison between responders and non responders in relation to TFC by ICON.
TFC by ICON Responders Non responders P value
Mean ±SD Mean ±SD
TFC0 38.09 9.86 26.29 9.12 .003
TFC5 36.69 10.52 27.03 11.07 .023
Average TFC 37.80 9.90 26.45 9.67 .004
DTFC 1.41 3.53 0.75 5.56 .203
% DTFC 3.75 10.08 2.50 21.45 .291
62 K.H. Mahmoud et al.
Figure 5 ROC curve for prediction of hypotension.
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Decisions during hemodialysis (HD) in critically ill patients are
usually challenging to determine the proper amount of ﬂuid
should be ﬁltered to unload while avoiding intradialytic
hypotension (IH). The evaluation of ﬂuid status is generally
approached from clinical observation of body weight change,
congestion, edema, blood pressure and chest X-ray. However,
evaluation on clinical grounds alone is not accurate enough in
HD patients. For this reason, more objective methods, such as
biochemical markers, bioimpedance analysis (BIA) and infe-
rior vena cava (IVC) diameters have been developed for the
assessment of ﬂuid status. However, no single method has
emerged as a gold standard, and the combination of these
methods is generally needed to complement their respective
limitations [9].
Electrical Cardiometry (EC) is a recently developed tech-
nology to measure the cardiac output. Both ICG and EC
derive CO from measurements of Thoracic Electrical Bioimpe-
dance (TEB) [3].
There is a real need to reﬁne FR based on a real-time indi-
cation of how much of the patient’s water is being removed
[10].
Our study showed a positive correlation between UF vol-
ume and TFC, these ﬁndings were in agreement with Wynne
et al. [5], who studied TFC using non invasive ICG in CRF
patients undergoing hemodialysis and Kossari et al. [11], De
Nicola and Sucre [12], who studied TFC using non invasive
ICG (NICCOMO, Medis, Germany) in critically ill patients
during CVVHDF proved the correlation between TFC and
FR., reported similar results using a new tool bioreactance.
An animal study by van de Water et al. [13], showed that, in
10 similarly anesthetized dogs overhydrated with intravenous
saline TFC closely correlated with the UF (r= 0.93). We
could not expect such a good value, considering that TFC
has a different range of normal values for both men and
women.Positive statistical agreement between TFC with CVP
before and after HD session was spotted in Piccoli et al. [14],
who found a positive correlation between CVP and bioimpe-
dance measurement in critically ill patients more than total
body water measured by bioimpedance vector analysis as well
as highlighted by our data.
Moreover, Ebert et al. [15] found a signiﬁcant linear corre-
lation between the alterations of central venous pressure and
the alterations of the thoracic baseline bioimpedance. Hence,
TFC should be a good indicator of ﬂuid status over time
and might help guide the need for and extent of FR during
HD, at least in each individual patient.
In our study 40% of the study population developed
hypotension as deﬁned previously (a decrease in
SBPP 20 mmHg or MAP> 10 mmHg).
This percentage agreed with previous studies that showed
an incidence of intradialytic hypotension ranging between
15% and 60% of various studies done by Wynne et al. [5],
Magdy et al. (40–60%) [16], John et al. (45–60%) [17], Pavan
et al. (18%) [18], Straver et al. (37.5%) [19]. The different pop-
ulations studied in prior studies that enrolled only CRF
patients could explain the discrepancy in the results.
Our results regarding (ICON) parameters showed that
there was a statistically signiﬁcant difference regarding TFC
in the subgroups studied, with lower TFC values in non
responders group compared to responders (26.45 kohm1 vs
37.8 kohm1) indicating that they were hypovolemic. Also
there was no statistically signiﬁcant difference regarding TFC
change (DTFC) between the 2 groups. The drop of BP was
transient in the responder group and persistent in non respon-
ders at the end of the dialysis session with no effect on SVR.
In our study we found that there was a statistically signiﬁ-
cant difference regarding MAP between responders and non
responders, whereby there was a drop of MAP values in the
non responders group from 92 ± 16.7 mmHg to 83
± 17.2 mmHg. In contrast MAP in the responders group
was changed during HD session then returned to the same
64 K.H. Mahmoud et al.value at the beginning of HD session (97.3 ± 1.31 mmHg–
94.5 ± 10.7 then 97.3 ± 11.4 mmHg at the end).
In our study there was no statistically signiﬁcant difference
regarding SVR, SVRI (BSA, WT), which were however higher
and dropped more in the non responders group.
This was in agreement with Straver et al. in 1998 [19], who
reported intradialytic hypotension during a deep fall in SVR
with a concomitant increase in heart rate. Although less pro-
nounced, CO and BV in the hypotensive group also decreased
more than in the stable group. Coritsidis et al. in 2003 [20],
found that changes in SVRI and HR were associated with
hypotension in diabetics undergoing HD [5]. Ahmed et al. in
2003 [21], found that 28 of 37 patients undergoing HD experi-
enced a BP drop and that, in 20 of these 28, a drop in SVR
occurred, resulting in clinical instability [5].
In our study 40% of the study population had persistent
congestion at the end of HD session. Also, Our study results
showed that there was no statistically signiﬁcant difference
between responders and non responders regarding lower limb
edema with P> 0.05. This was in agreement with Agarwal
et al. [22], who found that edema is of limited value in diagnos-
ing excess intravascular volume.
Our study results showed that there was a statistically sig-
niﬁcant difference between responders and non responders
regarding pulmonary congestion and congested neck veins
(P< 0.05). This was supported by Wang et al. in 2005 [23],
who performed a meta-analysis of 18 studies that evaluated
the utility of the history, physical examination, and diagnostic
tests in diagnosing HF and volume overload in patients pre-
senting to the emergency department with dyspnea. Among
all presenting symptoms, paroxysmal nocturnal dyspnea was
most helpful, followed closely by orthopnea and peripheral
edema.
They concluded that clinical examination is a poor predic-
tor of the patient’s volume status and ﬂuid resuscitation should
proceed cautiously, even in patients who are clinically
hypovolaemic.
According to Eisenberg et al. [24], when clinicians were
asked to predict hemodynamic parameters based only on his-
tory and physical examination, their performance was poor,
In this study, pulmonary artery occlusive (wedge) pressure
was correctly predicted only 30% of the time. CO, SVR, and
RAP were correctly predicted approximately 50% of the time.
In our study there was a statistically signiﬁcant difference
between responders and non responders regarding pulmonary
congestion in CXR with P< 0.05 with more congestion in
non responders.
In agreement with this ﬁnding, Milzman et al. [6], who con-
ducted a study in the heart failure population to determine if
there was a relationship between thoracic bioimpedance and
chest radiograph changes. Their data suggested a linear rela-
tionship between the grading of the severity of the CXR in
relation tointrathoracic ﬂuid volume, and the changes of mean
thoracic thoracic bioimpedance.
According to Peacock et al. in 2000 [7], there was no linear
relationship between a worsening radiographic appearance
and thoracic bioimpedance. They suspected that this was due
to the poor sensitivity of CXR for detecting pulmonary ﬂuid
in heart failure patients. The radiographs of chronic heart fail-
ure patients may not show ‘‘congestive” signs and may actually
have relatively normal CXR results despite excess thoracic vol-
ume. In chronic heart failure patients admitted to an ED withshortness of breath, thoracic bioimpedance determination may
be superior to CXR interpretation in determining ﬂuid state
and planning an appropriate treatment plan.
Our results regarding (ICON) parameters showed that
there was a statistically signiﬁcant difference regarding TFC
between subgroups with higher TFC values in non responders
compared to responders (43.14 ± 9.9 kohm1 vs 25.44
± 5.5 kohm1) indicating that they were still hypervolemic.
We assumed that the high TFC values at baseline and at
end of HD session would be anticipated in volume-
overloaded patients in need of more UF volume to improve
the clinical condition of the pts.
This ﬁnding was supported with the PREDICT study in
2006 [25], in which the correlation between stroke volume
and the values of TFC appeared to bear substantial prognostic
signiﬁcance for patients with congestive heart failure.
Our study found that there was a statistically signiﬁcant dif-
ference regarding CI (BSA, WT), where there were higher CI
(BSA) values in the non responders group than responders,
also CI (WT) values were higher in non responders.
In our study we investigated the predictive value of TFC in
relation to persistent congestion at end of HD session in HD
pts as an indicative of the ﬂuid status of HD pts to guide the
need for ultraﬁltration and to tailor UF goal accordingly.
ROC curves were plotted to determine the cutoff value of
TFC to predict persistent congestion.
To conclude our discussion, there was a correlation
between TFC measured by ICON, UF volume and volume
overload after HD sessions, hence it could be an objective
monitoring parameters to guide ﬂuid management and ultra
ﬁltration in critically ill patients. Also suggested cutoff values
of TFC could be usefully used as an objective tool to avoid
hemodynamic instability in association with other hemody-
namic parameters measured by ICON and to tailor individual
ﬂuid management of HD patients.
In conclusion hemodynamic instability is still a common
challenging complication during HD patients that contribute
to CVD risk as well as volume overload after HD session as
evident by electrical bioimpedance and clinical assessment.
Electrical bioimpedance using a new modiﬁed module
ICON is an evolving non-invasive tool for adjusting ﬂuid sta-
tus of critically ill patients on RRT using thoracic ﬂuid content
(TFC) as an indicator of ﬂuid status along with other hemody-
namic parameters that could be used to avoid hemodynamic
instability and persistent volume overload and congestion dur-
ing and after HD session. We recommend doing larger ran-
domized interventional studies to set clear protocols for UF
volume based on an objective tool to improve patients’
outcome.4.1. Study limitations
The small sample size is one of the limitations of our study and
lacking an objective gold standard for determining dry weight
which mainly depends on clinical assessment for that we aim to
present an objective mean to guide ﬂuid management with
future larger studies with a strict protocol for HD patients to
improve outcome and decreasing CVD morbidities.
Our study is a cross sectional observation study that lacks
intervention to adjust the UF volume based on our bioimpe-
dance measurements which were taken during one session of
Electrical Cardiometry in non invasive adjustment of ﬂuid status in renal patients 65HD, and decisions were left for nephrologists to changes HD
parameters.
We didn’t use an invasive hemodynamic technique to com-
pare with our results, we could answer this question as our
study wasn’t planned to validate the technique, rather aimed
to demonstrate the applicability of electrical bioimpedance
derived parameters to guide ﬂuid and hemodynamic manage-
ment in HD critically ill patients. Also there were many valida-
tion studies of the used technique that were compared to the
invasive TD technique.
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